DONSKOV, Frede; VIGGO JENSEN, Niels; SMIDT-HANSEN, Torben. A randomized phase II trial of interleukin-2 and interferon-α plus bevacizumab versus interleukin-2 and interferon-α in metastatic renal-cell carcinoma (mRCC): results from the Danish Renal Cancer Group (DaRenCa) study-1. Acta Oncologica, [S. l.], v. 57, n. 5, p. 589–594, 2018. DOI: 10.1080/0284186X.2018.1433324. Disponível em: https://medicaljournalssweden.se/actaoncologica/article/view/24718. Acesso em: 28 jun. 2026.